(Z)-3-[4-(1-(o-tolyl)-1H-1,2,3-triazol-4-yl)benzylidene]indolin-2-one

ID: ALA4873974

PubChem CID: 150073218

Max Phase: Preclinical

Molecular Formula: C24H18N4O

Molecular Weight: 378.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccccc1-n1cc(-c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)nn1

Standard InChI:  InChI=1S/C24H18N4O/c1-16-6-2-5-9-23(16)28-15-22(26-27-28)18-12-10-17(11-13-18)14-20-19-7-3-4-8-21(19)25-24(20)29/h2-15H,1H3,(H,25,29)/b20-14-

Standard InChI Key:  DPSGCNWEQKOKPX-ZHZULCJRSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   17.0317   -2.5176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0305   -3.3371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7386   -3.7461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7368   -2.1087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4454   -2.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4502   -3.3371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2346   -3.5870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7146   -2.9181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2268   -2.2551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4916   -4.3627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2919   -4.5279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5318   -2.9133    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5442   -5.3060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3437   -5.4714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8879   -4.8606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6270   -4.0817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8282   -3.9199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6898   -5.0228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0276   -5.7669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8397   -5.6757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.0038   -4.8751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2932   -4.4717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7453   -4.5385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4100   -5.0157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1535   -4.6786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2336   -3.8645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5640   -3.3886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8231   -3.7284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1573   -3.2546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  7 10  2  0
 10 11  1  0
  8 12  2  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 18  2  0
 15 18  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 21 23  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4873974

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKN-45 (2102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.44Molecular Weight (Monoisotopic): 378.1481AlogP: 4.74#Rotatable Bonds: 3
Polar Surface Area: 59.81Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.31CX Basic pKa: CX LogP: 5.52CX LogD: 5.52
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -1.13

References

1. Wang DP, Liu KL, Li XY, Lu GQ, Xue WH, Qian XH, Mohamed O K, Meng FH..  (2021)  Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold.,  211  [PMID:33340911] [10.1016/j.ejmech.2020.113083]

Source